Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31151904

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2019 Jul
First author
Fangusaro J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jul;20(7):900-901. doi: 10.1016/S1470-2045(19)30304-3.
    note
    Source null
    related pmid
    31151905
    relationship
    Comment in

Authors and identifiers

  1. name
    Fangusaro J
    type
    Author
  2. name
    Onar-Thomas A
    type
    Author
  3. name
    Young Poussaint T
    type
    Author
  4. name
    Wu S
    type
    Author
  5. name
    Ligon AH
    type
    Author
  6. name
    Lindeman N
    type
    Author
  7. name
    Banerjee A
    type
    Author
  8. name
    Packer RJ
    type
    Author
  9. name
    Kilburn LB
    type
    Author
  10. name
    Goldman S
    type
    Author
  11. name
    Pollack IF
    type
    Author
  12. name
    Qaddoumi I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fangusaro J
    type
    Author
  2. name
    Onar-Thomas A
    type
    Author
  3. name
    Young Poussaint T
    type
    Author
  4. name
    Wu S
    type
    Author
  5. name
    Ligon AH
    type
    Author
  6. name
    Lindeman N
    type
    Author
  7. name
    Banerjee A
    type
    Author
  8. name
    Packer RJ
    type
    Author
  9. name
    Kilburn LB
    type
    Author
  10. name
    Goldman S
    type
    Author
  11. name
    Pollack IF
    type
    Author
  12. name
    Qaddoumi I
    type
    Author
bibliography ids
  1. nci-bib-93463d4f1cf6556e3ebb7bc0
book metadata
content sha256
3ad9f3aea196400443e66098fac8ba415217f67bb9812639cd2f5155ab39a389
document type
citation
dois
  1. 10.1016/S1470-2045(19)30277-3
electronic publication date
display
2019 May 28
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31151904
immutable id
pubmed:31151904@3ad9f3aea196400443e66098fac8ba415217f67bb9812639cd2f5155ab39a389
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
1011-1022
volume
20
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2019 Jul;20(7):900-901. doi: 10.1016/S1470-2045(19)30304-3.
    note
    Source null
    related pmid
    31151905
    relationship
    Comment in
outcomes validated
false
pmid
31151904
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
ba9fd1b7670d9b155157cfeeeb88c09667848543436c7283371a4e4c67b97e63
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Jul
precision
month
year
2019
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31151904/
title
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

Preserved source evidence · Not medical advice